OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-CD2 antibodies

Anti-CD2 CAPTURE Antibody Clone OTI3E11

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA600310 Luminex and ELISA validated CD2 mouse monoclonal antibody (clone 3E1, clone OTI3E11 (formerly 3E11) 100ug $325 2 Weeks

Buy any antibody of 100ul or more, get a free package of 3 loading control antibody samples. View Details Add to Shopping Cart

spacer
LMNX(1)
ELISA(1)

OriGene Data

ImmunogenFull length human recombinant protein of human CD2 (NM_001767) produced in HEK293T cell.
Clone NameClone OTI3E11 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application *ELISA, LMNX Suggested Dilutions1:100 - 1:1000
BufferStored in PBS (pH 7.4) containing 0.05% sodium azide and up to 5% trehalose

Reference Data

Target NameHomo sapiens cyclin-dependent kinase 11B (CDK11B), transcript variant 1
Alternative NameCDC2L1; CDK11; CDK11-p110; CDK11-p46; CDK11-p58; CLK-1; p58; p58CDC2L1; p58CLK-1; PITSLREA;
Database LinkNP_001778
Entrez Gene 914 Human
Function
Related PathwayTranscription FactorsDruggable Genome

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

CD2 Elisa with 3E11 Capture (TA600310) and Anti-Tag 1B12 Detection (TA700050) Antibodies. Substrate used: Recombinant Human CD2 (LY400671)
spacer
CD2 Luminex Elisa with 3E11 Capture (TA600310) and Anti-Tag 1B12 Detection (TA700050) Antibodies. Substrate used: Recombinant Human CD2 (LY400671)
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title